Metastatic recurrence in colorectal cancer arises from residual EMP1+ cells A Cañellas-Socias, C Cortina, X Hernando-Momblona, S Palomo-Ponce, ... Nature 611 (7936), 603-613, 2022 | 125 | 2022 |
A transposable element insertion confers xenobiotic resistance in Drosophila L Mateo, A Ullastres, J González PLoS genetics 10 (8), e1004560, 2014 | 108 | 2014 |
Mex3a marks drug-tolerant persister colorectal cancer cells that mediate relapse after chemotherapy A Alvarez-Varela, L Novellasdemunt, FM Barriga, X Hernando-Momblona, ... Nature Cancer 3 (9), 1052-1070, 2022 | 74 | 2022 |
Iron accumulation drives fibrosis, senescence and the senescence-associated secretory phenotype M Maus, V López-Polo, L Mateo, M Lafarga, M Aguilera, E De Lama, ... Nature Metabolism 5 (12), 2111-2130, 2023 | 65 | 2023 |
A community challenge for a pancancer drug mechanism of action inference from perturbational profile data EF Douglass, RJ Allaway, B Szalai, W Wang, T Tian, A Fernández-Torras, ... Cell Reports Medicine 3 (1), 2022 | 48 | 2022 |
Pogo-like Transposases Have Been Repeatedly Domesticated into CENP-B-Related Proteins L Mateo, J Gonzalez Genome biology and evolution 6 (8), 2008-2016, 2014 | 48 | 2014 |
The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2 S Chaib, JA López-Domínguez, M Lalinde-Gutiérrez, N Prats, I Marin, ... Nature cancer 5 (3), 448-462, 2024 | 40 | 2024 |
Genome-wide patterns of local adaptation in Western European Drosophila melanogaster natural populations L Mateo, GE Rech, J González Scientific Reports 8 (1), 16143, 2018 | 22 | 2018 |
Personalized cancer therapy prioritization based on driver alteration co-occurrence patterns L Mateo, M Duran-Frigola, A Gris-Oliver, M Palafox, M Scaltriti, P Razavi, ... Genome Medicine 12, 1-23, 2020 | 21 | 2020 |
Identification and drug-induced reversion of molecular signatures of Alzheimer’s disease onset and progression in AppNL-G-F, AppNL-F, and 3xTg-AD mouse … E Pauls, S Bayod, L Mateo, V Alcalde, T Juan-Blanco, M Sánchez-Soto, ... Genome Medicine 13, 1-23, 2021 | 17 | 2021 |
Drug repositioning beyond the low-hanging fruits M Duran-Frigola, L Mateo, P Aloy Current Opinion in Systems Biology 3, 95-102, 2017 | 16 | 2017 |
Exploring the OncoGenomic Landscape of cancer L Mateo, O Guitart-Pla, M Duran-Frigola, P Aloy Genome Medicine 10, 1-8, 2018 | 9 | 2018 |
Bioactivity profile similarities to expand the repertoire of COVID-19 drugs M Duran-Frigola, M Bertoni, R Blanco, V Martínez, E Pauls, V Alcalde, ... Journal of Chemical Information and Modeling 60 (12), 5730-5734, 2020 | 6 | 2020 |
A PanorOmic view of personal cancer genomes L Mateo, O Guitart-Pla, C Pons, M Duran-Frigola, R Mosca, P Aloy Nucleic Acids Research 45 (W1), W195-W200, 2017 | 6 | 2017 |
The efficacy of chemotherapy is limited by intratumoural senescent cells that persist through the upregulation of PD-L2 S Chaib, JA López-Domínguez, M Lalinde, N Prats, I Marin, K Meyer, ... bioRxiv, 2022.11. 04.501681, 2022 | 5 | 2022 |
Genome-wide patterns of local adaptation in Drosophila melanogaster: adding intra European variability to the map L Mateo, GE Rech, J González bioRxiv, 269332, 2018 | 5 | 2018 |
Abstract C040: Investigating oncogene-inflammation cooperativity in pancreatic cancer K Woess, SB Araguás, A Diéguez, L Mateo, DA Curbelo Cancer Research 84 (2_Supplement), C040-C040, 2024 | | 2024 |
Systematic study of hybrid triplex topology and stability suggests a general triplex-mediated regulatory mechanism V Genna, G Portella, A Sala, M Terrazas, N Villegas, L Mateo, ... bioRxiv, 2024.05. 28.596189, 2024 | | 2024 |
Metastatic recurrence in colorectal cancer arises from residual EMP1+ cells E Batlle, A Caņellas Socias, C Cortina, X Hernando Momblona, ... Nature, 2022, vol. 611, p. 603–613, 2022 | | 2022 |
Additional file 2 of Identification and drug-induced reversion of molecular signatures of Alzheimer’s disease onset and progression in AppNL-GF, AppNL-F, and 3xTg-AD mouse models E Pauls, S Bayod, L Mateo, V Alcalde, T Juan-Blanco, M Sánchez-Soto, ... (No Title), 2021 | | 2021 |